| Literature DB >> 34232432 |
Ying Wu1, Li-Li Guo2, Lei Tian3,4, Ze-Quan Xu1, Qian Li1, Jian Hu1, Yi-Fei Huang1, Li-Qiang Wang5.
Abstract
PURPOSE: To compare the morphological and biomechanical properties of normal cornea and keratoconus at different stages.Entities:
Keywords: Corneal biomechanics; Corneal morphology; Corneal visualization Scheimpflug technology; Keratoconus
Mesh:
Year: 2021 PMID: 34232432 PMCID: PMC8536578 DOI: 10.1007/s10792-021-01929-4
Source DB: PubMed Journal: Int Ophthalmol ISSN: 0165-5701 Impact factor: 2.031
Corneal morphological and biomechanical parameters obtained with Pentacam and Corvis ST
| Parameters | Parameters | ||
|---|---|---|---|
| A2V | The second velocity of applanation | ||
| K1 | Steepest keratometric reading | HCT | Time from the start until the highest concavity |
| K2 | Flattest keratometric reading | PD | Peak distance |
| Km F | Mean keratometry from the anterior corneal surface | Radius | Central curvature radius at the highest concavity |
| Kmax | Maximum keratometry from the anterior corneal surface | A1DfL | Deflection length of the first applanation |
| Astig F | Central astigmatism from the anterior corneal surface | HC DfL | Deflection length of the highest concavity |
| CCT | Central corneal thickness | A2 DfL | Deflection length of the second applanation |
| TP | Pachymetry at the thinnest point | A1 DfA | Deflection amplitude of the first applanation |
| ISV | Index of surface variance | HC DfA | Deflection amplitude of the highest concavity |
| IVA | Index of vertical asymmetry | A2 DfA | Deflection amplitude of the second applanation |
| KI | Keratoconus index | DA Ratio 2 | The maximal value of the ratio between the deformation amplitude at the apex and at 2 mm from the corneal apex |
| CKI | Central keratoconus index | DA Ratio 1 | The maximal value of the ratio between the deformation amplitude at the apex and at 1 mm from the corneal apex |
| IHA | Index of height asymmetry | ARTh | Ambrósio relational thickness to the horizontal profile |
| IHD | Index of height decentration | bIOP | Biomechanical-corrected intraocular pressure |
| BAD-D | Belin-Ambrósio deviation | Integrated Radius | Inverse of the radius of curvature during the concave phase of the deformation |
| A1T | First applanation time | SPA1 | Stiffness parameter at the first applanation |
| A1V | First velocity of applanation | CBI | Corvis biomechanical index |
| A2T | Second applanation time | TBI | Tomographic and Biomechanical Index |
Differences in corneal morphological and biomechanical parameters between normal group and keratoconus group as well as KC at different stages. (skewed distribution, median and range of variation)
| NL group | KC | KC group | |||||
|---|---|---|---|---|---|---|---|
| Stage I KC | Stage II KC | Stage III KC | Stage IV KC | ||||
| K1 | 42.40(41.50–43.30) | 43.35(42.10–44.30) | 44.70(42.80–46.65) | 48.10(45.80–50.20) | 56.65(51.00–60.30) | 45.60(43.30–49.30) | < 0.001 |
| K2 | 43.95(43.00–44.90) | 45.85(44.70–47.20) | 48.00(45.60–49.80) | 52.60(50.30–55.30) | 60.35(55.40–65.30) | 48.90(46.30–53.80) | < 0.001 |
| Km | 43.20(42.40–44.00) | 44.65(43.30–45.70) | 46.20(44.20–48.10) | 50.00(48.30–52.60) | 58.75(53.80–62.80) | 47.20(44.60–51.30) | < 0.001 |
| Kmax | 44.40(43.70–45.60) | 47.65(45.70–48.90) | 52.25(50.05–54.65) | 60.90(57.90–63.30) | 73.00(67.30–80.00) | 54.00(49.10–62.30) | < 0.001 |
| Astig F | 1.20(0.80–1.90) | 2.60(1.50–3.40) | 3.05(2.00–4.45) | 4.20(2.90–6.00) | 4.00(2.20–6.60) | 3.30(2.00–4.80) | < 0.001 |
| CCT | 553.59(537.63–578.00) | 510.50(483.00–531.00) | 477.43(457.50–502.00) | 449.00(432.00–472.00) | 430.00(400.00–457.00) | 472.00(439.00–504.00) | < 0.001 |
| TP | 548.00(533.00–573.00) | 500.50(478.00–522.00) | 467.50(449.50–487.50) | 441.00(419.00–460.00) | 418.00(388.00–441.00) | 461.00(429.00–493.00) | < 0.001 |
| ISV | 17.00(14.00–22.00) | 37.00(33.00–41.00) | 62.50(52.00–74.00) | 101.00(94.00–112.00) | 156.50(142.00–175.00) | 75.00(46.00–112.00) | < 0.001 |
| IVA | 0.11(0.08–0.15) | 0.30(0.23–0.38) | 0.63(0.49–0.77) | 1.00(0.79–1.20) | 1.26(0.99–1.62) | 0.68(0.39–1.02) | < 0.001 |
| KI | 1.03(1.01–1.04) | 1.09(1.07–1.10) | 1.15(1.11–1.19) | 1.26(1.22–1.30) | 1.40(1.33–1.49) | 1.17(1.10–1.28) | < 0.001 |
| CKI | 1.01(1.00–1.01) | 1.02(1.01–1.02) | 1.04(1.02–1.07) | 1.10(1.07–1.14) | 1.19(1.15–1.25) | 1.05(1.02–1.12) | < 0.001 |
| IHA | 5.40(2.10–9.70) | 19.60(9.80–26.50) | 19.15(9.10–41.05) | 27.60(15.60–52.80) | 31.15(16.60–49.50) | 22.20(12.50–38.90) | < 0.001 |
| IHD | 0.01(0.01–0.01) | 0.03(0.02–0.04) | 0.08(0.06–0.10) | 0.15(0.12–0.17) | 0.23(0.18–0.27) | 0.10(0.05–0.16) | < 0.001 |
| BAD | 0.96(0.53–1.29) | 3.01(2.15–4.10) | 6.38(5.28–7.90) | 10.77(9.49–12.26) | 17.42(14.11–21.35) | 7.58(4.49–11.79) | < 0.001 |
| A1T | 7.40(7.24–7.59) | 7.19(7.01–7.33) | 7.02(6.87–7.17) | 6.96(6.79–7.13) | 6.92(6.73–7.08) | 7.02(6.87–7.21) | < 0.001 |
| A1V | 0.15(0.13–0.16) | 0.16(0.15–0.17) | 0.17(0.15–0.18) | 0.18(0.16–0.20) | 0.19(0.17–0.21) | 0.17(0.16–0.19) | < 0.001 |
| A2T | 21.81(21.52–22.04) | 21.96(21.73–22.19) | 22.07(21.85–22.35) | 22.16(21.90–22.37) | 22.22(21.86–22.42) | 22.12(21.83–22.35) | < 0.001 |
| A2V | −0.27(−0.29–0.25) | −0.29(−0.32–0.26) | −0.32(−0.34–0.28) | −0.34(−0.37–0.31) | −0.38(−0.44–0.32) | −0.32(−0.36–0.28) | < 0.001 |
| HCT | 16.86(16.63–17.13) | 16.86(16.63–17.33) | 16.86(16.63–17.19) | 16.86(16.40–17.09) | 16.86(16.63–17.09) | 16.86(16.63–17.09) | 0.763 |
| PD | 5.17(4.96–5.28) | 5.14(5.01–5.35) | 5.23(5.03–5.40) | 5.24(5.13–5.38) | 5.24(5.07–5.41) | 5.21(5.06–5.38) | < 0.001 |
| Radius | 7.31(6.95–7.94) | 6.44(5.83–7.02) | 5.65(5.06–6.35) | 5.27(4.73–5.70) | 4.38(3.82–5.16) | 5.55(4.84–6.42) | < 0.001 |
| A1 DfL | 2.33(2.22–2.42) | 2.31(2.20–2.37) | 2.35(2.23–2.43) | 2.41(2.25–2.52) | 2.48(2.33–2.63) | 2.36(2.24–2.48) | < 0.001 |
| HC DfL | 6.70(6.34–6.96) | 6.60(6.28–6.85) | 6.67(6.20–6.96) | 6.53(6.25–6.78) | 6.29(5.90–6.63) | 6.54(6.18–6.83) | < 0.001 |
| A2 DfL | 2.80(2.56–3.42) | 2.78(2.37–3.48) | 2.85(2.45–3.52) | 2.81(2.48–3.62) | 3.01(2.48–3.64) | 2.86(2.44–3.55) | 0.353 |
| A1 DfA | 0.10(0.09–0.10) | 0.10(0.09–0.10) | 0.10(0.10–0.11) | 0.11(0.10–0.12) | 0.13(0.12–0.14) | 0.11(0.10–0.12) | < 0.001 |
| HC DfA | 0.91(0.85–0.97) | 0.96(0.89–1.04) | 1.04(0.96–1.11) | 1.12(1.04–1.20) | 1.22(1.12–1.35) | 1.07(0.97–1.18) | < 0.001 |
| A2 DfA | 0.11(0.10–0.12) | 0.11(0.10–0.12) | 0.11(0.10–0.13) | 0.13(0.11–0.14) | 0.15(0.13–0.17) | 0.12(0.11–0.14) | < 0.001 |
| DA Ratio 2 | 4.06(3.85–4.30) | 4.62(4.34–5.29) | 5.31(4.76–6.01) | 6.13(5.70–6.80) | 7.25(6.10–8.81) | 5.67(4.79–6.52) | < 0.001 |
| DA Ratio 1 | 1.54(1.52–1.58) | 1.60(1.57–1.66) | 1.64(1.61–1.69) | 1.71(1.66–1.76) | 1.78(1.68–1.83) | 1.67(1.60–1.74) | < 0.001 |
| ARTh | 452.06(390.36–524.38) | 362.12(293.19–475.31) | 229.31(181.91–284.65) | 157.87(125.12–206.00) | 103.27(79.78–147.78) | 212.10(139.63–303.59) | < 0.001 |
| bIOP | 14.90(13.70–15.82) | 14.70(13.20–15.90) | 13.80(12.60–15.20) | 13.90(12.50–15.20) | 13.70(12.80–14.70) | 14.05(12.70–15.30) | < 0.001 |
| Integrated Radius | 7.75(7.31–8.35) | 9.33(8.44–10.42) | 10.90(9.74–12.39) | 12.41(11.30–13.74) | 14.82(12.08–17.55) | 11.31(9.56–13.24) | < 0.001 |
| SPA1 | 107.21(96.17–117.78) | 80.64(68.54–98.19) | 63.45(51.04–73.65) | 48.13(42.24–58.98) | 38.45(28.48–48.23) | 58.84(43.91–75.02) | < 0.001 |
| CBI | 0.01(0.00–0.07) | 0.69(0.01–0.99) | 1.00(0.97–1.00) | 1.00(1.00–1.00) | 1.00(1.00–1.00) | 1.00(0.96–1.00) | < 0.001 |
| TBI | 0.14(0.02–0.26) | 1.00(0.98–1.00) | 1.00(1.00–1.00) | 1.00(1.00–1.00) | 1.00(1.00–1.00) | 1.00(1.00–1.00) | < 0.001 |
KC keratoconus, NL normal cornea
ROC curve analysis of normal group and keratoconus at different stages
| Parameters | AUC (95% CI) | Cutoff | Sensitivity, % | Specificity, % |
|---|---|---|---|---|
| BAD-D | 0.989 | 1.595 | 0.959 | 1 |
| DA Ratio 2 | 0.921 | 4.742 | 0.768 | 0.975 |
| ARTh | 0.9 | 328.6 | 0.783 | 0.981 |
| Integrated Radius | 0.93 | 9.024 | 0.82 | 0.949 |
| SP-A1 | 0.94 | 79.13 | 0.802 | 0.981 |
| CBI | 0.916 | 0.516 | 0.845 | 1 |
| TBI | 0.993 | 0.515 | 0.967 | 1 |
| BAD-D | 0.963 | 1.595 | 1 | 1 |
| DA Ratio 2 | 0.811 | 4.35 | 0.746 | 0.816 |
| ARTh | 0.712 | 356.9 | 0.492 | 0.93 |
| Integrated Radius | 0.853 | 8.573 | 0.738 | 0.842 |
| SPA1 | 0.818 | 98.75 | 0.785 | 0.703 |
| CBI | 0.761 | 0.516 | 0.569 | 1 |
| TBI | 0.979 | 0.515 | 0.967 | 1 |
| BAD-D | 0.996 | 1.67 | 0.976 | 1 |
| DA Ratio 2 | 0.935 | 4.523 | 0.86 | 0.905 |
| ARTh | 0.926 | 328.6 | 0.823 | 0.981 |
| Integrated Radius | 0.937 | 9.18 | 0.848 | 0.962 |
| SPA1 | 0.965 | 85.66 | 0.939 | 0.918 |
| CBI | 0.946 | 0.516 | 0.896 | 1 |
| TBI | 0.997 | 0.574 | 0.988 | 1 |
| BAD-D | 1 | 3.02 | 1 | 1 |
| DA Ratio 2 | 0.983 | 4.903 | 0.944 | 0.994 |
| ARTh | 0.985 | 313.4 | 0.976 | 0.987 |
| Integrated Radius | 0.980 | 9.423 | 0.936 | 0.987 |
| SPA1 | 0.989 | 77.22 | 0.944 | 0.981 |
| CBI | 0.975 | 0.718 | 0.952 | 1 |
| TBI | 0.997 | 0.71 | 0.984 | 1 |
| BAD-D | 1 | 3.32 | 1 | 1 |
| DA Ratio 2 | 0.964 | 4.806 | 0.86 | 0.905 |
| ARTh | 0.995 | 258.1 | 0.823 | 0.981 |
| Integrated Radius | 0.958 | 9.696 | 0.848 | 0.962 |
| SPA1 | 0.998 | 72.27 | 0.939 | 0.918 |
| CBI | 0.996 | 0.701 | 0.896 | 1 |
| TBI | 0.997 | 0.566 | 0.988 | 1 |
KC keratoconus, NL normal cornea, AUC area under the receiver operating characteristic curve
Fig. 1ROC curves of the different groups a NL group vs. KC group, b NL group vs. stage I KC group, c NL group vs. stage II KC group, d NL group vs. stage III KC group, e NL group vs. stage IV KC group
Comparison of ROC curves of different parameters among groups
| Two curves under comparison | D 0 | P 0 | D 1 | P 1 | D 2 | P 2 | D 3 | P 3 | D 4 | P 4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAD-D | DA Ratio 2 | 7.164 | < 0.001 | 6.073 | < 0.001 | 4.425 | < 0.001 | 1.803 | 0.071 | 2.080 | 0.037 |
| ARTh | 8.381 | < 0.001 | 8.849 | < 0.001 | 4.494 | < 0.001 | 1.649 | 0.098 | 1.003 | 0.316 | |
| Integrate | 6.602 | < 0.001 | 4.976 | < 0.001 | 4.170 | < 0.001 | 2.094 | 0.036 | 2.534 | 0.011 | |
| SP-A1 | 5.973 | < 0.001 | 6.029 | < 0.001 | 3.170 | 0.0015 | 2.087 | 0.036 | 1.327 | 0.185 | |
| CBI | 7.478 | < 0.001 | 7.030 | < 0.001 | 3.495 | < 0.001 | 2.106 | 0.035 | 0.996 | 0.319 | |
| TBI | − 1.194 | 0.232 | − 1.803 | 0.071 | − 0.518 | 0.604 | 1.386 | 0.166 | 0.993 | 0.321 | |
| DA Ratio 2 | ARTh | 2.014 | 0.044 | 3.238 | 0.001 | 0.672 | 0.501 | − 0.274 | 0.784 | − 1.740 | 0.082 |
| Integrate | − 1.206 | 0.228 | − 2.157 | 0.031 | − 0.118 | 0.905 | 0.521 | 0.602 | 0.334 | 0.738 | |
| SP-A1 | − 2.254 | 0.024 | − 0.301 | 0.763 | − 0.301 | 0.763 | − 1.126 | 0.260 | − 2.009 | 0.044 | |
| CBI | 0.528 | 0.597 | 2.005 | 0.045 | − 2.843 | 0.005 | 0.650 | 0.516 | − 1.775 | 0.075 | |
| TBI | − 7.325 | < 0.001 | − 6.527 | < 0.001 | − 4.524 | < 0.001 | − 1.620 | 0.105 | − 1.872 | 0.061 | |
| ARTh | Integrate | − 2.629 | 0.009 | − 4.732 | < 0.001 | − 0.688 | 0.491 | 0.450 | 0.652 | 2.130 | 0.033 |
| SP-A1 | − 2.311 | 0.021 | − 3.539 | < 0.001 | − 2.848 | 0.044 | − 0.458 | 0.646 | − 0.827 | 0.408 | |
| CBI | − 2.392 | 0.017 | 2.547 | 0.011 | − 1.784 | 0.074 | 0.981 | 0.326 | − 1.009 | 0.313 | |
| TBI | − 8.549 | < 0.001 | − 8.766 | < 0.001 | − 4.589 | < 0.001 | − 1.682 | 0.092 | − 0.985 | 0.324 | |
| Integrate | SP-A1 | − 1.113 | 0.266 | 1.471 | 0.141 | − 2.130 | 0.033 | − 1.458 | 0.145 | − 2.460 | 0.014 |
| CBI | 1.342 | 0.180 | 3.271 | 0.001 | − 0.590 | 0.554 | 0.404 | 0.686 | − 2.232 | 0.026 | |
| TBI | − 6.801 | < 0.001 | − 5.538 | < 0.001 | − 4.294 | < 0.001 | − 1.836 | 0.066 | − 2.331 | 0.019 | |
| SP-A1 | CBI | 2.983 | 0.003 | 2.389 | 0.017 | 1.770 | 0.076 | 1.358 | 0.175 | 0.717 | 0.472 |
| TBI | − 6.506 | < 0.001 | − 6.843 | < 0.001 | − 3.273 | 0.001 | − 1.489 | 0.136 | 0.517 | 0.605 | |
| CBI | TBI | − 7.610 | < 0.001 | − 7.339 | < 0.001 | − 3.592 | < 0.001 | − 1.998 | 0.046 | − 0.923 | 0.355 |
D: Statistics of Delong test; 0: NL group vs. KC group; 1. NL group vs. stage I KC group; 2: NL group vs. stage II KC group; 3: NL group vs. stage III KC group; 4: NL group vs. stage IV KC group
Due to multiple comparisons, the test level was corrected according to Bonferroni principle, and p < 0.0023 was considered as statistically significant
Comparison of ROC curves of the same parameter in diagnosing keratoconus at different stages
| parameter | D0 | D1 | D2 | D3 | D4 | D5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BAD-D | − 2.989 | 0.003 | − 3.401 | < 0.001 | − 3.401 | < 0.001 | − 1.468 | 0.138 | − 1.468 | 0.138 | NA | NA |
| DA Ratio 2 | − 4.509 | < 0.001 | − 5.965 | < 0.001 | − 4.756 | < 0.001 | − 2.731 | 0.006 | − 1.272 | 0.204 | 0.936 | 0.35 |
| ARTh | − 5.902 | < 0.001 | − 8.1039 | < 0.001 | − 8.620 | < 0.001 | − 3.194 | 0.0015 | − 4.008 | < 0.001 | − 0.953 | 0.341 |
| Integrated Radius | − 3.069 | 0.002 | − 5.087 | < 0.001 | − 3.718 | < 0.001 | − 2.489 | 0.013 | − 0.981 | 0.327 | 1.148 | 0.251 |
| SP-A1 | − 5.458 | < 0.001 | − 6.670 | < 0.001 | − 7.144 | < 0.001 | − 2.147 | 0.032 | − 3.271 | < 0.001 | − 1.603 | 0.110 |
| CBI | − 5.343 | < 0.001 | − 6.339 | < 0.001 | − 7.435 | < 0.001 | − 1.515 | 0.13 | − 3.192 | 0.0015 | − 1.642 | 0.102 |
| TBI | − 2.389 | 0.017 | − 2.282 | 0.023 | − 2.249 | 0.025 | 0.182 | 0.855 | 0.08 | 0.936 | − 0.072 | 0.94 |
D: Statistics of Delong test; 0: stage I KC group vs. stage II KC group; 1: stage I KC group vs. stage III KC group; 2: stage I KC group vs. stage IV KC group; 3: stage II KC group vs. stage III KC group; 4: stage II KC group vs. stage IV KC group; 5: stage III KC group vs. stage IV KC group
Due to multiple comparisons, the test level was corrected according to Bonferroni principle, and p < 0.005 was considered as statistically significant